Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- A2960 LoratadineTarget: Histamine H1 ReceptorsSummary: Peripheral HH1R antagonist
- A1684 AprepitantTarget: Substance P/NK1 ReceptorSummary: Substance P (SP) inhibitor
- A5166 Ondansetron HClTarget: 5-HT3 ReceptorsSummary: 5-HT3 receptor antagonist
- A8446 IbuprofenTarget: COXSummary: inhibitor of cyclooxygenase 1 and cyclooxygenase 2
- A8449 IndomethacinTarget: COXSummary: Cox inhibitor
- B5624 STF 083010Target: Inositol-requiring enzyme 1 (IRE1)Summary: IRE1α endonuclease inhibitor
- B2240 OlanzapineTarget: 5-HT2 Receptors|D2 ReceptorsSummary: Antagonist of 5-HT2A and dopamine D2 receptors
- B2231 Amitriptyline HClTarget: Trk Receptors|5-HT2 Receptors|Norepinephrine transporter|5-HT TransportersSummary: Serotonin /norepinephrine receptor/5-HT4/5-HT2 inhibitor
- B1564 RanitidineTarget: Histamine H2 ReceptorsSummary: Histamine H2-receptor antagonist
- A3136 A-740003Target: P2X ReceptorsSummary: P2X7 receptor antagonist